Covered recipient · General Payments record
MYLINDA CRIPE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,157.06
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $329.20 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $82.09 | 5 |
| DEXCOM, INC. | $53.36 | 2 |
| Otsuka America Pharmaceutical, Inc. | $36.75 | 2 |
| ABBVIE INC. | $36.47 | 2 |
| Amgen Inc. | $34.56 | 2 |
| Lilly USA, LLC | $34.20 | 2 |
| Tempus AI, Inc | $20.09 | 1 |
| Novo Nordisk AS | $18.62 | 1 |
| Dynavax Technologies Corporation | $13.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.47 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106967159 | CMS |
| ABBVIE INC. | $19.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106967161 | CMS |
| Amgen Inc. | $19.17 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231093 | CMS |
| Amgen Inc. | $15.39 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231095 | CMS |
| Dexcom, Inc. | $29.27 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153380516 | CMS |
| Dexcom, Inc. | $24.09 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153380518 | CMS |
| Dynavax Technologies Corporation | $13.06 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082152101 | CMS |
| Lilly USA, LLC | $15.54 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135929980 | CMS |
| Lilly USA, LLC | $18.66 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135873057 | CMS |
| Novo Nordisk Inc | $18.62 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100575812 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.87 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119051690 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.88 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119051692 | CMS |
| PFIZER INC. | $14.02 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131145591 | CMS |
| PFIZER INC. | $15.40 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131073253 | CMS |
| PFIZER INC. | $16.70 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132031349 | CMS |
| PFIZER INC. | $19.57 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132031760 | CMS |
| PFIZER INC. | $16.40 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131885289 | CMS |
| Tempus AI, Inc | $20.09 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150179819 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.